Curie Therapeutics
Boston
About Curie Therapeutics
Curie Therapeutics is a fully integrated, next-generation radiopharmaceuticals company focused on pioneering a new class of targeted radiopharmaceuticals that are both safe and effective. Curie's radiopharmaceuticals are composed of rationally designed conjugates against carefully selected biological targets, to deliver alpha and beta-emitting radionuclide payloads.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $75.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2021)
- Website: curietherapeutics.com
Industries & Categories
Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/curie-therapeutics-91880 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.